Amendment No. 1 to Promissory Note 11-2 between ProUroCare Medical Inc. and Maslon, Edelman, Borman & Brand, LLP
This amendment updates the terms of a promissory note originally issued by ProUroCare Medical Inc. to Maslon, Edelman, Borman & Brand, LLP. The changes extend the note's maturity date to August 10, 2013, and set the conversion price at $1.00 per share. All other terms of the original note remain unchanged. The amendment is effective as of September 27, 2012.
Amendment No. 1 to
Promissory Note 11-2 Dated February 10, 2011
This Amendment No. 1 to Promissory Note 11-2 dated February 10, 2011 issued by ProUroCare Medical Inc. in favor of Maslon, Edelman, Borman & Brand, LLP (the “Note”) is made to amend the Maturity Date and the Conversion Price of the Note.
The following defined terms of the Note are hereby changed as defined below:
| “Maturity Date” | The Maturity Date shall be August 10, 2013. |
| “Conversion Price” | The Conversion Price shall be $1.00 per share. |
No other defined terms or clauses of the Note are changed.
This Amendment No. 1 is dated and effective as of September 27, 2012
Maslon, Edelman, Borman & Brand, LLP
/s/Paul Chestovich, Partner______
ProUroCare Medical Inc.
/s/ Richard Thon_________________
Richard Thon
Chief Financial Officer
